Document is current
Any future updates will be listed below
-
Authors
Ito, Ryuta https://orcid.org/0000-0001-5111-3361
Ishii, Hideki
Oshima, Satoru
Nakayama, Takuya
Sakakibara, Takashi
Kakuno, Motohiko
Murohara, Toyoaki
- License Information
-
More Information
Article History
Received: 12 December 2023
Accepted: 15 May 2024
First Online: 23 May 2024
Declarations
:
: This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Ethics Committee of Nagoya Kyoritsu Hospital.
: H.I. received lecture fees from Astellas Pharma Inc., Astrazeneca Inc., Bayer Pharmaceutical Co., Ltd., Bristol-Myers Squibb Inc., Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Pharma Inc., and MSD K. K. T.M. received lecture fees from Bayer Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Kowa Co., Ltd., MSD K.K., Mitsubishi Tanabe Pharma Co., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma K.K., Pfizer Japan Inc., Sanofi-aventis K.K., and Takeda Pharmaceutical Co., Ltd. The remaining authors declare no conflicts of interest.
